Inspire Medical Systems (INSP) Total Non-Current Liabilities (2017 - 2026)
Inspire Medical Systems (INSP) posted Total Non-Current Liabilities of $119.0 million for Q1 2026, down 5.62% sequentially from $126.1 million in Q4 2025, and up 25.29% YoY from $95.0 million in Q1 2025.
Inspire Medical Systems (INSP) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Inspire Medical Systems has reported Total Non-Current Liabilities for 10 years, with the latest figure at $119.0 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 25.29% year-over-year to $119.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $119.0 million (up 25.29% YoY) and the FY2025 annual result came in at $126.1 million, up 6.34% from the prior year.
- Total Non-Current Liabilities eased to $119.0 million in Q1 2026 per INSP's latest filing, from $126.1 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $141.1 million in Q3 2025 and troughed at $57.2 million in Q3 2022.
- A 5-year average of $95.3 million and a median of $95.2 million in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities declined 2.22% in 2022, then soared 66.46% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $68.7 million in 2022, then soared by 49.81% to $103.0 million in 2023, then climbed by 15.14% to $118.5 million in 2024, then rose by 6.34% to $126.1 million in 2025, then slipped by 5.62% to $119.0 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $119.0 million, $126.1 million, and $141.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Inspire Medical Systems | 1.75 Bn | 1.43 Bn | 171.46 Mn | 100.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100.28 Mn |
| Mar 31, 2026 | 118.97 Mn |
| Dec 31, 2025 | 126.05 Mn |
| Sep 30, 2025 | 141.15 Mn |
| Jun 30, 2025 | 124.27 Mn |
| Mar 31, 2025 | 94.96 Mn |
| Dec 31, 2024 | 118.54 Mn |
| Sep 30, 2024 | 99.48 Mn |
| Jun 30, 2024 | 90.17 Mn |
| Mar 31, 2024 | 96.67 Mn |
| Dec 31, 2023 | 102.95 Mn |
| Sep 30, 2023 | 95.17 Mn |
| Jun 30, 2023 | 88.74 Mn |
| Mar 31, 2023 | 67.05 Mn |
| Dec 31, 2022 | 68.72 Mn |
| Sep 30, 2022 | 57.17 Mn |
| Jun 30, 2022 | 64.87 Mn |
| Mar 31, 2022 | 64.52 Mn |
| Dec 31, 2021 | 65.90 Mn |
| Sep 30, 2021 | 58.47 Mn |